$0.11
(6.18%)
Add to watchlist
Create an alert
Stocks and Shares ISACodexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Company Information
About this company
Key people
Stephen G. Dilly
Chairman of the Board
Alison Moore
President, Chief Executive Officer, Director
Georgia L. Erbez
Chief Financial Officer
Kevin Norrett
Chief Operating Officer
David V. Smith
Lead Independent Director
Cynthia Collins
Independent Director
Raymond De Vre
Independent Director
Esther Martinborough
Independent Director
H. Stewart Parker
Independent Director
Click to see more
Key facts
- Shares in issue90.32m
- EPICCDXS
- ISINUS1920051067
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$150.84m
- Employees188
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.